Balance Sheet
Accounts PayablesAccumulated DepreciationAssetsCash & EquivalentsCommon EquityCurrent AssetsFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityMinority InterestNon-Current AssetsOther Non-Current AssetsPayablesPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

60 Degrees Pharmaceuticals (SXTPW) Assets (2022 - 2025)

Historic Assets for 60 Degrees Pharmaceuticals (SXTPW) over the last 4 years, with Q3 2025 value amounting to $6.7 million.

  • 60 Degrees Pharmaceuticals' Assets fell 985.8% to $6.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was $6.7 million, marking a year-over-year decrease of 985.8%. This contributed to the annual value of $5.8 million for FY2024, which is 2600.83% down from last year.
  • Latest data reveals that 60 Degrees Pharmaceuticals reported Assets of $6.7 million as of Q3 2025, which was down 985.8% from $4.2 million recorded in Q2 2025.
  • 60 Degrees Pharmaceuticals' Assets' 5-year high stood at $9.2 million during Q3 2023, with a 5-year trough of $1.3 million in Q4 2022.
  • Its 4-year average for Assets is $6.2 million, with a median of $6.7 million in 2025.
  • As far as peak fluctuations go, 60 Degrees Pharmaceuticals' Assets soared by 50004.12% in 2023, and later plummeted by 4119.57% in 2024.
  • 60 Degrees Pharmaceuticals' Assets (Quarter) stood at $1.3 million in 2022, then soared by 500.04% to $7.8 million in 2023, then decreased by 26.01% to $5.8 million in 2024, then rose by 16.15% to $6.7 million in 2025.
  • Its Assets stands at $6.7 million for Q3 2025, versus $4.2 million for Q2 2025 and $6.0 million for Q1 2025.